Imagine a silent killer that clogs the veins of olive trees and grapes, drying them out from the inside. This effort is like building a high-tech security system to stop this pest at the border and a medical kit to heal infected orchards. It focuses on finding naturally tough plants and using non-chemical cleaners to keep the trade of plants safe.
Xylella fastidiosa destroys high-value crops and landscapes, leading to severe economic losses and trade restrictions. Current control methods are often insufficient or rely on chemicals that conflict with EU environmental goals.
A suite of early detection tools, non-chemical nursery treatments, a database of resistant plant genotypes, and digital Decision Support Systems for pest management.
If you are a nursery dealing with strict quarantine laws and the risk of crop loss — this project developed non-chemical treatments for nursery stock that ensure your plants meet phytosanitary standards for safe trade.
If you are a tech firm dealing with the need for precision farming tools — this project developed Decision Support Systems and IPM protocols that help farmers manage outbreaks in both conventional and organic production.
If you are a grower dealing with dead zones in your fields — this project identified resistant genotypes in major EU-affected crops to help you restore your land and maintain productivity.
Based on available project data, specific pricing for the treatments or software is not provided as the project is currently in the research and development phase.
The project aims to deliver practical and applicable solutions for European agriculture and forestry, including the use of sentinel plots and botanical gardens to test effectiveness.
Based on available project data, specific licensing terms are not listed, but the project includes a dedicated work package (WP9) for technology transfer and knowledge exchange.
Yes, the project is specifically aligned with the EU Plant Health Law and the EU Green Deal to ensure solutions meet official phytosanitary standards.
The project runs from 2022-09-01 to 2026-08-31, meaning full results and tools will be finalized by late 2026.
The consortium is highly diversified with 31 partners across 14 countries, showing a strong global reach including the US, Brazil, and Israel. While dominated by research (10) and university (9) entities, there is a significant industrial presence with 5 companies and 4 SMEs, representing a 16% industry ratio, which suggests a clear path for commercializing the resulting tools.
Contact AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS in Spain
Contact us to connect with the BeXyl consortium for early access to resistant genotype data.
